ClinicalTrials.gg
Not yet recruitingNCT05930392Updated Jul 5, 2023

Comparative Evaluation of Microsurgery vs Conventional Surgical Technique of Gingival Depigmentation

An interventional study of Gingival depigmentation using microsurgery and Conventional surgical depigmentation in Gingival Pigmentation and Melanosis, sponsored by Postgraduate Institute of Dental Sciences Rohtak. Not yet recruiting at 1 site in India. Open to participants aged 20 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-07-05.

Sponsored by Postgraduate Institute of Dental Sciences Rohtak · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Sep 2023, 3 years 1 month ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
22
Allocation
Randomized
Ages
20 Years to 45 Years
Sex
All
01

Study summary

Gingiva being the most frequently pigmented tissue of the oral cavity challenges a lot of people with an esthetic concern. Increased production of melanin, a pigment produced by the melanocytes present in the basal and suprabasal cell layers of the epithelium leads to the hyper-pigmented appearance. Over the decades many non-surgical as well as surgical techniques have been developed to manage the melanin induced hyper-pigmentation of gingival tissue with comparable efficacies. Till date, the most common gingival depigmentation procedure with satisfactory results remains the conventional scalpel (#15 blade) method. Nowadays, minimally traumatising the surgical field and gaining maximum outputs with help of microscopy and microsurgical instruments has attained a level of utmost importance in surgical procedures including periodontal therapy. Improved results in terms of increased vascularization of the grafts, relatively better percentages of root coverage a significant increase in width and thickness of keratinized tissue, an improved esthetic outcome and decreased patient morbidity in cases of gingival recession treated via microsurgical approach have been observed and well documented. However, perusal of the literature available suggests that clinical outcomes and esthetic potential of the results of gingival depigmentation using principles of microsurgery is an area of interest that still needs to be explored further. This study is therefore aimed at evaluating and comparing the clinical, esthetic and patient-related outcomes of gingival depigmentation performed using microsurgery vs conventional surgical technique.

Read the detailed description

AIM: To evaluate and compare the clinical, esthetic and patient-related outcomes of gingival depigmentation performed via microsurgery vs conventional surgical technique.

OBJECTIVES:

  1. To evaluate and compare melanin pigmentation using Dummett Oral Pigmentation Index (DOPI), Hedin melanin index (HMI) between both the treatment modalities at baseline, 1 week, 1 month and 3 months post-operatively.
  2. To assess a) patient-related outcome measures (PROMs) such as post-operative pain perception/discomfort on a visual analog scale (VAS) , patient's preference of the mode of treatment /esthetic satisfaction and b) clinical parameters such as bleeding, redness, swelling, wound healing, gingival colour, gingival morphology at baseline, within 24 hours, 1 week, 1 month and 3 months.
  3. To evaluate the effect of different treatment modalities on melanocyte histopathologic count (MHC).

TIME FRAME: 3 months SAMPLE SIZE: To achieve a power of 80%, level of significance of 5% and assuming an effect size of 0.8, a minimum sample size of 18 patients is needed in each group. Accounting for a 20% drop out rate, 22 patients are needed in each group.

METHODOLOGY: Patients fulfilling the eligibility criteria will be enrolled in the study after obtaining an informed written consent. A split-mouth design with maxillary and mandibular anteriors being randomly allocated into test (microsurgery) and control (conventional surgical depigmentation) technique to each patient using a radio-opaque box having 44 chits.

STATISTICAL ANALYSIS: Data recorded will be processed by standard statistical analysis. The normality of distribution of data will be examined by Shapiro Wilk test. Statistical analysis will be performed according to distribution of data. If it is in normal distribution, intra group comparison will be done by paired t-test between two time points and inter group comparison will be done by using unpaired t-test between two groups. If it is in non-normal distribution, intra group comparison will be done by Wilcoxon signed rank test and inter group comparison will be done by Mann-Whitney U test.

SETTING: Department of Periodontology and Oral Implantology, PGIDS, Rohtak, Haryana.

STUDY DESIGN: Split-mouth Comparative Randomised Controlled Clinical Study.

02

Conditions studied

  • Gingival Pigmentation
  • Melanosis

Browse trials for

03

In context

Melanosis

170 studies on the registry are indexed under Melanosis; 46 are open to participants now.

This study's planned enrollment of 22 is below the median of 40 across 157 interventional studies indexed under Melanosis.

Browse Melanosis studies →

Lead sponsor

Postgraduate Institute of Dental Sciences Rohtak is the lead sponsor of 213 studies on the registry; 72 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

1)Systemically healthy patients seeking treatment for gingival hyper-pigmentation

Exclusion criteria

Exclusion Criteria:

  1. Gingival index (Loe and Sillness 1963) of greater than or equal to 1 at any site of surgical field.
  2. patients with periodontitis
  3. patients with pathologic or drug-induced gingival hyper-pigmentation
  4. patients with history of systemic illness with the potential to influence the periodontal status or outcome of periodontal intervention;
  5. patients with Miller Grade II /Grade III tooth mobility;
  6. patients taking medications such as NSAIDS, , statins or calcium channel blockers, which are known to influence periodontal status;
  7. pregnant or lactating women;
  8. history of use of tobacco;
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
22 participants (estimated)

Study arms

  • Active comparator
    GINGIVAL DEPIGMENTATION USING MICROSURGERY

    Surgical excision of hyper-pigmented gingival tissue using microsurgical blade (keratome 2.2) and magnification loupes under local anaesthesia. Application of periodontal dressing followed by post-operative instructions.

    Procedure: Gingival depigmentation using microsurgery

  • Active comparator
    Conventional surgical technique of gingival depigmentation

    Surgical excision of hyper-pigmented gingival tissue using conventional surgical blade (#15) under local anaesthesia. Application of periodontal dressing followed by post-operative instructions.

    Procedure: Conventional surgical depigmentation

Interventions

  • ProcedureGingival depigmentation using microsurgery

    GINGIVAL DEPIGMENTATION USING MICROSURGICAL BLADE AND MAGNIFICATION LOUPES

  • ProcedureConventional surgical depigmentation

    GINGIVAL DEPIGMENTATION USING CONVENTIONAL SURGICAL TECHNIQUE

06

What researchers measure

Primary outcomes

  1. CLINICAL PARAMETER- Bleeding

    bleeding score classified in accordance to Ishi et al and Kawashima et al A: NONE B: SLIGHT C: MODERATE D: SEVERE

    Time frame: 3 MONTHS

  2. CLINICAL PARAMETER- REDNESS

    redness score classified in accordance to Ishi et al and Kawashima et al A: NONE B: SLIGHT C: MODERATE D: SEVERE

    Time frame: 3 MONTHS

  3. CLINICAL PARAMETER- swelling

    swelling score classified in accordance to Ishi et al and Kawashima et al A: NONE B: SLIGHT C: MODERATE D: SEVERE

    Time frame: 3 MONTHS

  4. CLINICAL PARAMETER- WOUND HEALING

    Wound healing score classified in accordance to Ishi et al and Kawashima et al A: COMPLETE EPITHELIALIZATION B: INCOMPLETE OR PARTIAL EPITHELIALIZATION C: ULCER D: TISSUE DEFECT OR NECROSIS

    Time frame: 3 MONTHS

  5. CLINICAL PARAMETER- Gingival color

    Gingival Color A: IMPROVEMENT B: SLIGHT IMPROVEMENT C: NO CHANGE D: DETERIORATION

    Time frame: 3 MONTHS

  6. DUMMETT ORAL PIGMENTATION INDEX (DOPI)

    DOPI Score Criteria 0 Pink tissue (no clinical pigmentation) 1. Mild light brown tissue (mild clinical pigmentation) 2. Medium brown or mixed brown and pink tissue (moderate clinical pigmentation) 3. Deep brown/ blue-black tissue (heavy clinical pigmentation)

    Time frame: 3 MONTHS

  7. HEDIN MELANIN INDEX (HMI)

    HMI Score Criteria 0 No pigmentation 1. One or two solitary units of pigmentation in the papillary gingiva 2. \>3 units of pigmen- tation in the papillary gingiva without formation of a continuous ribbon 3. More than equal to 1 short continuous ribbons of pigmentation 4. One continuous ribbon including the entire area between the canines

    Time frame: 3 MONTHS

  8. Patient-related outcome measures (PROMs) - post-operative pain perception

    Pain will be assessed on a 100-mm horizontal, continuous interval scale with the left endpoint marked ''no pain'' and the right endpoint marked ''worst pain.'' The patient placed a mark to coincide with the level of pain. Scores were calculated as: 0 = no pain; 0.1 to 3.0 cm (1 to 30 mm) = slight pain; 3.1 to 6.0 cm (31 to 60 mm) = moderate pain; 6.1 to 10 cm (61 to 100 mm) = severe pain.

    Time frame: 3 months

  9. Patient-related outcome measures (PROMs) - ESTHETIC SATISFACTION

    ESTHETIC SATISFACTION WILL BVE EVALUATED AS PER PATIENT'S RESPONSE TO PREFERRED CHOICE OF TREATMENT - CONVENTIONAL OR MICROSURGICAL

    Time frame: 3 months

Secondary outcomes

  1. MELANOCYTE HISTOPATHOLOGIC COUNT (MHC)

    EFFECT ON MELANOCYTE HISTOPATHOLOGIC COUNT The activity of the melanocytes will be measured at baseline and 3 months post-operatively, by microscopically viewing the density of melanin granules.35 The grading will be done using the following scale: 0 = absence of melanin granules (no pigmentation); 1 = rare and scattered melanin granules (mild pigmentation); 2 = dense but not aggregated melanin granules (moderate pigmentation); or 3 = dense and aggregated melanin granules (heavy pigmentation).

    Time frame: 3 MONTHS

  2. PERIODONTAL PARAMETER - PLAQUE INDEX

    PLAQUE INDEX " SCORE" "CRITERIA" 0 No plaque 1. A film of plaque adhering to the free gingival margin and adjacent area of the tooth. The plaque could only be recognized by running a probe across the tooth surface area 2. Moderate accumulation of soft deposits within the gingival pocket, or the tooth and gingival margin, which can be seen with the naked eyes. 3. Abundance of soft matter on tooth and/or on the gingival margin.

    Time frame: 3 MONTHS

  3. PERIODONTAL PARAMETERS - GINGIVAL INDEX,

    GINGIVAL INDEX Score Criteria 0 Absence of inflammation/normal gingiva. 1. Mild inflammation, slight change in colour, slight oedema; no bleeding on probing within 30 seconds. 2. Moderate inflammation; moderate glazing, redness, oedema, hypertrophy and bleeding on probing. 3. Severe inflammation; marked redness and hypertrophy ulceration of gingival margin. Tendency to spontaneous bleeding.

    Time frame: 3 MONTHS

  4. PERIODONTAL PARAMETERS - BLEEDING ON PROBING (BOP)

    BLEEDING ON PROBING BOP will be recorded as 1 (present) if it occurs within 15 secs of probing and 0 (absent) if no bleeding occurs. It will be calculated in %. After adding all the scores, total score will be divided by the total number of surfaces accessed and multiplied by 100. It will be designed as % sites

    Time frame: 3 MONTHS

  5. PERIODONTAL PARAMETER - PROBING POCKET DEPTH (PPD)

    PROBING POCKET DEPTH Probing pocket depth will be measured as the distance from the gingival margin to the base of pocket. The probing depth measurements will be assessed using a calibrated manual periodontal probe (PCP-UNC 15 Hu-Friedy, Chicago, IL, USA). The probe will be inserted with a firm, gentle pressure to the bottom of the pocket and maintained parallel to the vertical axis of the tooth. Measurements will be noted at 6 sites of each tooth - mesio-buccal, mid-buccal, disto-buccal, mesio-lingual, mid-lingual and disto-lingual. Measurements will be rounded to the nearest whole millimetre.

    Time frame: 3 MONTHS

  6. PERIODONTAL PARAMETER - CLINICAL ATTACHMENT LEVEL (CAL)

    CLINICAL ATTACHMENT LEVEL Clinical Attachment Level will be measured as the distance between the base of the pocket and the cemento-enamel junction (CEJ). Measurements will be made at 6 sites of each tooth- mesio-buccal, mid-buccal, disto-buccal, mesio-lingual, mid-lingual and disto-lingual using UNC-15 probe.

    Time frame: 3 MONTHS

  7. PERIODONTAL PARAMETERS - GINGIVAL RECESSION (GR)

    GINGIVAL RECESSION Recession will be measured as the vertical distance from the CEJ to the deepest part of gingival margin in the middle of the buccal aspect of the crown.

    Time frame: 3 MONTHS

07

Study locations

1 site
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 5, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05930392
Responsible party
Sponsor
First posted
Jul 5, 2023
Start date
Jul 1, 2023 (estimated)
Primary completion
Sep 25, 2023 (estimated)
Completion
Oct 10, 2023 (estimated)
Last update
Jul 5, 2023

Study contacts

RAJINDER KR SHARMA, MDS
Contact
rksharmamds@yahoo.in
9416358222
AANCHAL SAHNI, BDS
principal investigator · POST GRADUATE INSTITUTE OF DENTAL SCIENCES,ROHTAK

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion